Methylcobalamin + Folic Acid Injection

Overview

• Methylcobalamin - the active neurological form of Vitamin B12
• Folic acid (Vitamin B9) - essential for DNA synthesis and one-carbon metabolism

Mechanism of Action

Methylcobalamin

1. Methionine synthesis: Methylcobalamin donates its methyl group to convert homocysteine → methionine (via methionine synthase). Methionine is then converted to S-adenosylmethionine (SAM), the universal methyl donor for myelin synthesis and neurotransmitter metabolism.
2. Folate recycling: This reaction simultaneously releases tetrahydrofolate (THF) from the "methyl trap" (methyltetrahydrofolate). Without B12, folate becomes trapped as methyltetrahydrofolate and cannot be used for DNA synthesis.
3. Myelin maintenance: Through SAM-mediated methylation, methylcobalamin supports myelin sheath integrity - the basis of its use in peripheral neuropathy.

Folic Acid

• Purine and pyrimidine synthesis (hence DNA replication)
• Conversion of homocysteine to methionine (via 5-methylTHF, the folate-B12 interaction)
• Amino acid metabolism (serine-glycine interconversion, histidine catabolism)

Indications

Why Methylcobalamin Over Cyanocobalamin?

Dosage and Administration

• Acute/severe deficiency with neurological symptoms: 1000 mcg (1 mg) IM daily for 1-2 weeks, then weekly until stable, then monthly for life
• Maintenance (pernicious anemia): 1000 mcg IM every 4 weeks
• Neuropathy (diabetic/others): 500 mcg IM 3x/week OR 1500 mcg IM/week; often combined with oral dosing
• Folic acid component: Typically 1-5 mg; for megaloblastic anemia, 1 mg daily; for pregnancy prevention, 400-800 mcg daily; therapeutic doses up to 5 mg

Pharmacokinetics

• Absorption: After IM injection, methylcobalamin is rapidly absorbed into blood and bound to transcobalamin II for tissue transport
• Distribution: ~90% of B12 stored in liver (1-10 mg total body stores); turnover 0.5-8 mcg/day
• Excretion: Excess cobalamin is excreted renally; no dose adjustment needed in mild renal impairment
• Folic acid: Rapidly absorbed after IM injection; converted in liver to active THF polyglutamates; excess renally excreted

Adverse Effects

• Injection site pain, redness
• Nausea, diarrhea (mild, transient)
• Headache, dizziness
• Peripheral sensation of swelling
• Rare but serious: Anaphylaxis/anaphylactic shock (test dose recommended if cobalt hypersensitivity suspected)
• Hypokalemia can occur during initial treatment (rapid red cell production consumes potassium)

• Generally well tolerated
• Rare allergic reactions
• May mask neurological symptoms of untreated B12 deficiency (see warning below)

Critical Drug Interaction / Warning

Folic acid must NEVER be given alone to treat megaloblastic anemia without excluding B12 deficiency first.

• Metformin: Reduces B12 absorption with chronic use; injection bypasses this
• Proton pump inhibitors / H2 blockers: Reduce B12 absorption; injection unaffected
• Methotrexate: Folate antagonist; folic acid supplementation required
• Phenytoin / antiepileptics: Can reduce folate levels; may also reduce B12
• Concurrent iron deficiency: Can blunt response to B12/folate therapy; treat iron deficiency simultaneously

Monitoring

• Serum B12 levels (target >200 pg/mL)
• CBC, reticulocyte count - should rise at 3-5 days and peak at 7-10 days
• Serum homocysteine and methylmalonate (more sensitive markers)
• Serum potassium during initial treatment (hypokalemia risk)
• Neurological assessment at 3-6 month intervals

Clinical Notes

• Neurological improvement after B12 injection is slower than haematological response. Deficits present for a few months may resolve fully; those present for years may be permanent.
• B12 therapy (in pernicious anemia) must be maintained for life once started.
• The RDA for B12 is 2.4 mcg/day; therapeutic injectable doses far exceed this to ensure tissue saturation when absorption is compromised.
• Serum B12 can be falsely normal in hepatic disease or myeloproliferative disorders (due to release of storage forms bound to transcobalamin I/III, which are not available to tissues).

Symptoms of Iron Deficiency

Stages of Iron Depletion

General Symptoms (from Anemia)

• Fatigue and weakness - the most common symptom; persistent even with mild activity
• Pallor - of skin, conjunctiva, nail beds, and mucous membranes
• Shortness of breath - on exertion (heart works harder to compensate)
• Palpitations / tachycardia - compensatory increase in heart rate
• Dizziness and lightheadedness
• Headache
• Reduced exercise tolerance
• Poor concentration and difficulty thinking (iron is needed for brain function independent of anemia)
• Irritability
• Cold intolerance (reduced peripheral circulation)

Specific / Classic Signs of Iron Deficiency

In Children and Infants

• Irritability and restlessness
• Poor attention span and learning difficulties
• Delayed psychomotor development
• Reduced immune function (increased susceptibility to infection)
• Poor growth and weight gain

In Pregnancy

• Same general fatigue/pallor signs
• Increased risk to the fetus: preterm birth, low birth weight, impaired fetal brain development

Laboratory Clues (not symptoms, but confirm diagnosis)

Key Clinical Point

In well-nourished adults in developed countries, microcytic hypochromic anemia is a symptom, not a disease - it signals an underlying cause (e.g. GI bleeding from colon cancer, peptic ulcer, menorrhagia). Always investigate the source.

Methylcobalamin + Folic Acid Injection - Routes of Administration

Short Answer

Available Routes

Intramuscular (IM) - The Preferred Route

• Methylcobalamin: Given as a deep IM injection (usually gluteal muscle), given undiluted
• Folic Acid: Given undiluted IM directly
• Best for routine therapy, neuropathy, and deficiency correction
• Allows good tissue storage of B12 in the liver

Intravenous (IV) - Can Be Used, With Conditions

Methylcobalamin IV:

• Technically possible but not preferred - IV administration results in very rapid urinary excretion (50-98% excreted in urine within 48 hours, most within the first 8 hours), leaving little opportunity for liver storage
• Reserved for severe/acute deficiency or when IM is not possible

Folic Acid IV:

• Must be diluted before IV use - never give concentrated folic acid injection undiluted into a vein
• Dilution: add folic acid to Normal Saline (NS) or 5% Dextrose (D5W)
• Example: 5 mg folic acid in 1 mL + 49 mL NS = 0.1 mg/mL solution
• Diluted solution stable for 30 hours (protect from light)

Adding to IV Drip ("Indirect Syringe" / Infusion)

• Add to Normal Saline or 5% Dextrose - both are compatible
• Protect from light - B12 and folic acid are both light-sensitive; wrap the bag/tubing in foil if infusing over time
• Used in patients on parenteral nutrition or when oral/IM routes are not available (e.g., severe malabsorption, ICU patients)

Important Practical Points

1. IM is always preferred for methylcobalamin - better tissue retention and liver storage
2. Never give undiluted folic acid IV - dilute first
3. Light protection is important - both vitamins degrade with light exposure
4. Anaphylaxis risk - always have resuscitation equipment ready for the first injection; an intradermal test dose is recommended if cobalt hypersensitivity is suspected
5. IV route increases speed of excretion for B12 - use IM unless there is a specific clinical reason for IV